The Silverstein Foundation For Gba Research
- Assets
- $3.3m
- Revenue
- $272.2k
- Investments
- $0.0
- Employees
- 0
- Location
- New York, NY
- Founding
- 09/2017
- Data as of
- 12/2021
- EIN
- 82-0656623
Organization Overview
The Silverstein Foundation For Gba Research is located in New York, NY. The organization was established in 2017. According to its NTEE Classification (T30) the organization is classified as: Public Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Silverstein Foundation For Gba Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Silverstein Foundation For Gba Research generated $272.2k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 5 years, the organization has seen revenues fall by an average of (46.5%) each year. All expenses for the organization totaled $1.6m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Silverstein Foundation For Gba Research has awarded 20 individual grants totaling $6,467,011. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO RAISE AWARENESS AROUND PARKINSON'S DISEASE ASSOCIATED WITH GBA MUTATIONS; SEE PART III.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SINCE THE LAUNCH OF THE SILVERSTEIN FOUNDATION IN MARCH OF 2017, IT HAS FUNDED OVER 30 GRANTS, RECEIVED DONATIONS FROM OVER 1000 DONORS AND SUPPORTED 7 DIFFERENT THERAPEUTIC APPROACHES, INCLUDING AUTOPHAGY, ANTISENSE OLIGONUCLEOTIDES, GENE THERAPY, ALPHA SYNUCLEIN DEGRADERS, GLUCOCEREBROSIDASE ACTIVATORS, SUBSTRATE REDUCTION THERAPY, AND AUTOLOGOUS INDUCED PLURIPOTENT STEM CELLS TO ACCELERATE RESEARCH AND CLINICAL TRIALS TO BRING NEW THERAPEUTIC OPTIONS TO PATIENTS. SEE SCHEDULE O.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jonathan Silverstein President / Secretary | OfficerTrustee | 2 | $0 |
Natalie Silverstein Vice President / Treasurer | OfficerTrustee | 1 | $0 |
Geoffrey Levin Board Member | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $36,790 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $36,790 |
| Total Program Service Revenue | $0 |
| Investment income | $2,372 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $232,991 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $272,153 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,481,425 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $35,974 |
| Fees for services: Accounting | $24,200 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $19,693 |
| Advertising and promotion | $0 |
| Office expenses | $2,790 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $1,564,082 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $3,206,167 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $71,678 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $3,277,845 |
| Accounts payable and accrued expenses | $18,915 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $18,915 |
| Net assets without donor restrictions | $3,258,930 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $3,277,845 |
Grants Awarded
Over the last fiscal year, The Silverstein Foundation For Gba Research has awarded $1,481,425 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
ACUREX THERAPEUTICS PURPOSE: RESEARCH | $1,000,000 |
PURPOSE: RESEARCH | $481,425 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that The Silverstein Foundation For Gba Research has recieved totaling $10,000.
| Awarding Organization | Amount |
|---|---|
Schwab Charitable Fund San Francisco, CA PURPOSE: PUBLIC, SOCIETAL BENEFIT | $10,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Partnership Schools New York, NY | $64,379,139 | $24,282,663 |
Feeding Pennsylvania Lemoyne, PA | $10,818,120 | $21,841,545 |
Royal College Of Art Usa Inc New York, NY | $1,933,182 | $14,916,047 |
Imago Dei Fund Boston, MA | $57,020,766 | $29,637,241 |
Boston Charitable Trust Fund Boston, MA | $1,173,216 | $4,494,143 |
Nfa Foundation Inc Norwich, CT | $77,129,817 | $5,415,738 |
American Friends Of B Nai Levy Foundation Brooklyn, NY | $493,786 | $13,431,000 |
Rf Catalytic Capital Inc New York, NY | $241,603,034 | $246,273,218 |
University Of Pittsburgh And Upmc Medical And Health Sciences Fdn Pittsburgh, PA | $0 | $12,874,250 |
Freedom Fund Brooklyn, NY | $51,719,352 | $51,201,158 |
American Friends Of Leket Israel Inc Teaneck, NJ | $3,165,709 | $12,922,662 |
Provision Ministry Inc Westborough, MA | $833,220 | $12,247,682 |